
Foundation Frontiers: A Medical Education Webinar
Event Format
Date
Thu, Jun 13, 2024, 12:00 PM – Thu, Jun 13, 2024, 01:00 PMCost
Type
Event Host

Description
Foundation Frontiers: A Medical Education Webinar
Fusion Detection in Advanced Non-Small Cell Lung Cancer: Stay up to Date
Thursday, June 13, 2024
1 - 2 p.m. Eastern; noon - 1 p.m. Central; 10 - 11 a.m. Pacific
On-demand Webinar
In non-small cell lung cancer (NSCLC), targetable driver alterations include ALK*, RET**, and ROS1*** fusions. DNA-based and RNA-based next-generation sequencing each have advantages and drawbacks for detecting gene fusions. In this webinar, expert speakers will present their perspectives on fusion detection in NSCLC.
Attendees Will Learn:
- Summary of currently approved therapies for fusions in NSCLC.
- Methods and recommendations for fusion detection with comprehensive genomic profiling.
- The pros and cons of DNA and RNA sequencing for fusion detection.
- About fusion detection in the context of a hypothetical patient case.
Speakers:
Mark Socinski, MD
Executive Director (Thoracic Cancer), Medical Oncologist
AdventHealth Cancer Institute
Orlando, FL
Holli Dilks, PhD
Senior Director, Global Head of Field Medical
Foundation Medicine
Boston, MA
* Anaplastic lymphoma kinase (ALK)
** rearranged during transfection (RET)
*** ROS proto-oncogene 1, receptor tyrosine kinase (ROS1)
Sponsored By
